ADAR1 Capital Management, LLC

Position in CAPR — Capricor Therapeutics, Inc.

CIK 1940272 AUSTIN, TX

Back to CAPR Full portfolio

Position in CAPR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,181,479

-$572,548 QoQ

Shares Held

90,593

0.0% QoQ

Ownership

0.156%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#46

of 169 holders

Holding Since

Jun 2024

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in CAPR Over Time

Shares Held

Position Value (USD)

Derivatives in CAPR

reported options exposure · as of Dec 31, 2024

CallValue

$1,311,000

CallShares

95,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ADAR1 Capital Management, LLC holds $1,760,452,202 across 192 Biotechnology names. CAPR ranks #106 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	1,804,703	$240,494,721
2	PTGX	Protagonist Therapeutics, Inc	960,863	$117,782,586
3	ROIV	Roivant Sciences Ltd.	3,157,008	$111,726,513
4	IMVT	Immunovant, Inc.	2,330,716	$89,802,487
5	ZLAB	Zai Lab Ltd	3,369,034	$64,011,646
6	AGIO	Agios Pharmaceuticals, Inc.	1,288,053	$47,799,646
7	CRNX	Crinetics Pharmaceuticals, Inc.	1,222,080	$45,730,233
8	CYTK	Cytokinetics Inc	457,907	$39,009,097

All Filings in CAPR

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,181,479	90,593	0.0%	Shares	Sole	2026-08-14
2026-03-31	$2,754,027	90,593	+61.4%	Shares	Sole	2026-05-18
2024-12-31	$774,456	56,120	+130.9%	Shares	Sole	2025-02-13
2024-12-31	$1,311,000	95,000	—	Call	Sole	2025-02-13
2024-09-30	$369,709	24,307	—	Shares	Sole	2024-11-14
2024-06-30	$97,308	20,400	—	Put	Sole	2024-08-13
No filing history on record for this holder in this stock.